Ann: S66 Quarterly Update, page-6

Some really pleasing results here and continues to fly under the radar due to low liquidity.

If they can maintain the same trajectory should clear $50m revenue comfortably which would be a strong starting point before they bring on the new production lines to double production. All eyes on being cash flow positive this quarter with the higher degree of contract manufacturing.

Whilst I support the aggressive plan to double production (especially since paid for with a huge premium placement), I think they should spend some money on branding and packaging of the vitamins and other products!